Dr. Marika Mokou studied Biology at the School of Biology, University of Athens, Greece and received her bachelor’s degree in 2011 (Grade: 7.91/10). Later on, in 2014, she obtained her Master’s degree in Molecular Medicine from the Medical School of Athens, Greece (Grade: 9.64/10). In 2015, Dr. Mokou started working as a PhD student in the Proteomics Laboratory at BRFAA in collaboration with the Laboratory of Biology at the Medical School of Athens in Greece. Her PhD studies were financially supported for 3 years by the European Commission (SysVasc, HEALTH 2013, Grant No. 603288). During her PhD studies, Dr. Mokou gained numerous awards and distinctions and her work was presented in prestigious conferences and journals. 

Dr. Mokou received her PhD in 2019 (Grade: 10/10). Directly after her PhD studies, Dr. Mokou pursued post-doctoral studies for one year at the Proteomics Laboratory in BRFAA under the supervision of Dr. Antonia Vlahou. Since June 2020, Dr. Mokou works as a Marie Skłodowska-Curie PostDoctoral Fellow at Mosaiques Diagnostics in Hannover, Germany under the supervision of Prof. Dr. Dr. Harald Mischak and she is focusing on drug repurposing for bladder cancer through the exploitation of patients' omics signatures. Dr. Mokou has experience in molecular biology techniques, in vivo and in vitro experiments, proteomics methods and bioinformatics analysis of –omics data and serves as a Reviewer in many in peer reviewed journals. Her research interests are focused on bladder cancer pathophysiology and therapeutics.